Skip to content

Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)

Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall Hernias: a Multicenter International Randomized Controlled Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05575141
Acronym
ROCSTAR
Enrollment
0
Registered
2022-10-12
Start date
2025-07-01
Completion date
2033-01-01
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Wall Hernia, Ventral Incisional Hernia

Keywords

Abdominal Wall Hernia, robotic TAR (rTAR), open TAR (oTAR), transversus abdominis release (TAR)

Brief summary

In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.

Interventions

Incisional hernia repair for the treatment of wide ventral incisional hernias.

Sponsors

Algemeen Ziekenhuis Maria Middelares
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

This is an open-label Randomized Controlled Trial (RCT) where the patient, surgeon, research coordinators and hospital staff will be aware of the treatment arm after randomization. As the open approach is performed using a large midline incision, whereas the robotic approach applies only 6 or 7 small incisions (or less if no posterior component separation is needed), blinding of patients and physicians is difficult. Evaluation of the radiographic imaging of the abdominal wall at 24 months (MRI or CT scan) will be done by radiologists at the local participating center blinded to the randomized treatment arm. This will be a blinded evaluation for the presence or absence of hernia recurrence. Data analysis will be performed in a blinded manner by an independent statistician.

Intervention model description

a multicenter international randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- All patients requiring treatment of a wide ventral incisional hernia (of more than 8 centimetres in width)

Exclusion criteria

* Pregnant or suspected pregnancy * Not-curatively treated malignancy, with life expectancy less than 24 months * Patients unable to give informed consent or complete study specific questionnaires * Emergency surgery * Primary ventral hernia repair * Exclusively lateral hernias not involving the midline * Incisional hernia repair after open abdomen or enterocutaneous fistula * Active wound infection * Previous anterior or posterior component separation * Patients with an existing ostomy * Patients with a life expectancy of less than 24 months * Patients suspected of being unable to comply with the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Length of postoperative hospital stayhours from the end of surgery (last skin suture) until discharge, assessed up to 20 daysLength of postoperative hospital stay

Secondary

MeasureTime frameDescription
Skin-to-skin operative timePer-operative (minutes)Skin-to-skin operative time from first incision until last skin suture
Conversion ratePer-operativeConversion rate from the robotic-assisted approach to the open approach
Surgical site related complications30 daysSurgical site infection - surgical site occurrence - surgical site occurrence requiring procedural interventions
Readmission rate30 Days and 3 months postoperativeReadmission rate
Post-anesthetic discharge scoring systemFrom the end of surgery (last skin suture) until discharge, assessed up to 20 daysMinimum score is 0, maximum score is 12. The higher the score, the better the outcome.
Postoperative visual analogue scale pain scoreFrom the end of surgery (last skin suture) until discharge, assessed up to 20 daysMinimum score is 0, maximum score is 10. The higher the score, the worse the outcome.
EuraHS Quality of Life ScoringPreoperatively, 30 days, 3 months, 12 months, 24 months, 60 monthsMinimum score is 0, maximum score is 90. The higher the score, the worse the outcome.
Body Image ScalePreoperatively, 30 days, 3 months, 12 months, 24 months, 60 monthsMinimum score is 0, maximum score is 10. A higher score means a higher level of body image disturbance (worse outcome).
Hernia recurrence30 days, 3 Months, 12 months, 24 months, 60 monthsHernia recurrence
Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence30 days, 3 Months, 12 months, 24 months, 60 monthsReoperation for hernia recurrence or abdominal surgery not for hernia recurrence
Postoperative complications30 daysPostoperative complications classified acoording to the Clavien-Dindo Classification
Reoperation rate30 daysReoperation rate

Contacts

PRINCIPAL_INVESTIGATORFilip Muysoms, MD PhD

Clinical research center Maria Middelares

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026